CCNG2 and liver dysplastic nodule: Our findings delineate a previously unidentified function for cyclin G2, as a protective factor against the pathologic progression of tubulointerstitial fibrosis, and suggest that the interaction between cyclin G2 and the Wnt signalling pathway renders a new therapeutic target for tubulointerstitial fibrosis in DN.